At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AEMD Aethlon Medical
Pre-Mkt 09-25 07:59:22 EDT
6.77
-0.04
-0.59%
盘前6.57
-0.20-2.89%
07:46 EDT
High6.81Low6.36Vol152.09K
Open6.69D1 Closing6.81Amplitude6.61%
Mkt Cap10.86MTradable Cap10.83MTotal Shares1.60M
T/O1.01MT/O Rate9.51%Tradable Shares1.60M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)
TIPRANKS  ·  09-24 20:50
Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
Benzinga Earnings  ·  09-17
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
Aethlon Medical Announces Merger with North Immunology
TIPRANKS  ·  09-17
Aethlon Medical Announces Merger with North Immunology
M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema
TIPRANKS  ·  09-17
M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema
U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical
Reuters  ·  09-17
U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical, North Immunology enter all-stock transaction
TIPRANKS  ·  09-17
Aethlon Medical, North Immunology enter all-stock transaction
Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology
THOMSON REUTERS  ·  09-17
Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology
Aethlon Medical Agrees All-Stock Merger with North Immunology
Reuters  ·  09-17
Aethlon Medical Agrees All-Stock Merger with North Immunology
Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co
THOMSON REUTERS  ·  09-17
Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co
Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology
THOMSON REUTERS  ·  09-17
Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology
Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln
THOMSON REUTERS  ·  09-17
Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln
Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company
THOMSON REUTERS  ·  09-17
Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company
Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028
THOMSON REUTERS  ·  09-17
Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028
Aethlon Medical & North Immunology Announce Merger to Advance Novel Il-13 X Il-18 Bispecific Antibody for Atopic Dermatitis
THOMSON REUTERS  ·  09-17
Aethlon Medical & North Immunology Announce Merger to Advance Novel Il-13 X Il-18 Bispecific Antibody for Atopic Dermatitis
Aethlon Medical - Stockholders to Receive Contingent Value Right for Each Share Held
THOMSON REUTERS  ·  09-17
Aethlon Medical - Stockholders to Receive Contingent Value Right for Each Share Held
Aethlon Medical - Combined Entity to Operate as North Immunology, and Trade Under Ticker Nrtx
THOMSON REUTERS  ·  09-17
Aethlon Medical - Combined Entity to Operate as North Immunology, and Trade Under Ticker Nrtx
Aethlon Medical Amends CEO, CFO and CMO Deals to Pay Change-in-Control Severance in Lump Sum
Reuters  ·  09-15
Aethlon Medical Amends CEO, CFO and CMO Deals to Pay Change-in-Control Severance in Lump Sum
Aethlon Medical Announces Annual Shareholder Meeting
Reuters  ·  09-01
Aethlon Medical Announces Annual Shareholder Meeting
Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization
TIPRANKS  ·  08-31
Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization
Aethlon Medical Says All Pre-Funded Warrants are Exercised
Reuters  ·  08-31
Aethlon Medical Says All Pre-Funded Warrants are Exercised

Introduction

Company Name.
Aethlon Medical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Issue price:
--